These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Vergès B Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175 [TBL] [Abstract][Full Text] [Related]
7. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. de Vries R; Borggreve SE; Dullaart RP Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331 [TBL] [Abstract][Full Text] [Related]
8. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model. Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480 [TBL] [Abstract][Full Text] [Related]
9. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665 [TBL] [Abstract][Full Text] [Related]
10. Lipid and lipoprotein dysregulation in insulin resistant states. Avramoglu RK; Basciano H; Adeli K Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697 [TBL] [Abstract][Full Text] [Related]
11. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics. Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Oida K; Takeda R Artery; 1981; 9(6):477-93. PubMed ID: 6802107 [TBL] [Abstract][Full Text] [Related]
12. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women. Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090 [TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
14. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice. Salerno AG; Patrício PR; Berti JA; Oliveira HC Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484 [TBL] [Abstract][Full Text] [Related]
16. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Riemens SC; van Tol A; Sluiter WJ; Dullaart RP Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595 [TBL] [Abstract][Full Text] [Related]
17. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats. Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Diabetic Dyslipidemia. Hirano T J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913 [TBL] [Abstract][Full Text] [Related]
19. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Heimberg M; Olubadewo JO; Wilcox HG Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084 [TBL] [Abstract][Full Text] [Related]
20. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice. Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]